nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketamine—CYP2C8—Cyclosporine—focal segmental glomerulosclerosis	0.252	0.36	CbGbCtD
Ketamine—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.176	0.251	CbGbCtD
Ketamine—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.171	0.244	CbGbCtD
Ketamine—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.102	0.146	CbGbCtD
Ketamine—OPRK1—Peptide ligand-binding receptors—AGT—focal segmental glomerulosclerosis	0.00063	0.00211	CbGpPWpGaD
Ketamine—DRD2—G alpha (i) signalling events—AGTR2—focal segmental glomerulosclerosis	0.000629	0.0021	CbGpPWpGaD
Ketamine—GRIN1—Spinal Cord Injury—TGFB1—focal segmental glomerulosclerosis	0.000625	0.00209	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000622	0.00208	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000618	0.00207	CbGpPWpGaD
Ketamine—OPRD1—G alpha (i) signalling events—AGT—focal segmental glomerulosclerosis	0.000606	0.00203	CbGpPWpGaD
Ketamine—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.000601	0.00201	CbGpPWpGaD
Ketamine—ABCB1—Allograft Rejection—CD40LG—focal segmental glomerulosclerosis	0.0006	0.00201	CbGpPWpGaD
Ketamine—DRD2—Circadian rythm related genes—GNAQ—focal segmental glomerulosclerosis	0.000599	0.00201	CbGpPWpGaD
Ketamine—OPRK1—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.000595	0.00199	CbGpPWpGaD
Ketamine—OPRM1—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.000592	0.00198	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000591	0.00198	CbGpPWpGaD
Ketamine—DRD2—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.000584	0.00195	CbGpPWpGaD
Ketamine—OPRD1—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.000581	0.00194	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.000572	0.00191	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	0.000535	0.00179	CbGpPWpGaD
Ketamine—OPRM1—Peptide ligand-binding receptors—AGT—focal segmental glomerulosclerosis	0.000532	0.00178	CbGpPWpGaD
Ketamine—OPRK1—G alpha (i) signalling events—AGT—focal segmental glomerulosclerosis	0.000532	0.00178	CbGpPWpGaD
Ketamine—ABCB1—HIF-1-alpha transcription factor network—NOS2—focal segmental glomerulosclerosis	0.000531	0.00178	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000523	0.00175	CbGpPWpGaD
Ketamine—OPRD1—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.000522	0.00174	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00052	0.00174	CbGpPWpGaD
Ketamine—OPRK1—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.000509	0.0017	CbGpPWpGaD
Ketamine—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.000508	0.0017	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.000503	0.00168	CbGpPWpGaD
Ketamine—DRD2—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.0005	0.00167	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000499	0.00167	CbGpPWpGaD
Ketamine—OPRD1—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.000482	0.00161	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—LPL—focal segmental glomerulosclerosis	0.000479	0.0016	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000475	0.00159	CbGpPWpGaD
Ketamine—OPRM1—TCR Signaling Pathway—TGFB1—focal segmental glomerulosclerosis	0.00047	0.00157	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—LPL—focal segmental glomerulosclerosis	0.000467	0.00156	CbGpPWpGaD
Ketamine—OPRK1—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.000457	0.00153	CbGpPWpGaD
Ketamine—GRIN1—Axon guidance—MMP2—focal segmental glomerulosclerosis	0.00045	0.0015	CbGpPWpGaD
Ketamine—OPRM1—G alpha (i) signalling events—AGT—focal segmental glomerulosclerosis	0.000449	0.0015	CbGpPWpGaD
Ketamine—DRD2—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.000449	0.0015	CbGpPWpGaD
Ketamine—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	0.000448	0.0015	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000444	0.00148	CbGpPWpGaD
Ketamine—OPRD1—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.000442	0.00148	CbGpPWpGaD
Ketamine—GRIN2B—Axon guidance—MMP2—focal segmental glomerulosclerosis	0.000438	0.00147	CbGpPWpGaD
Ketamine—OPRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00043	0.00144	CbGpPWpGaD
Ketamine—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.000423	0.00141	CbGpPWpGaD
Ketamine—SLC6A2—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.000417	0.00139	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000403	0.00135	CbGpPWpGaD
Ketamine—OPRK1—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.000388	0.0013	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.000387	0.00129	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.000386	0.00129	CbGpPWpGaD
Ketamine—DRD2—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.000385	0.00129	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.000383	0.00128	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.000381	0.00127	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000368	0.00123	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000367	0.00123	CbGpPWpGaD
Ketamine—OPRD1—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.000367	0.00123	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000365	0.00122	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000362	0.00121	CbGpPWpGaD
Ketamine—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.000357	0.00119	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000354	0.00118	CbGpPWpGaD
Ketamine—DRD2—Circadian rythm related genes—NOS2—focal segmental glomerulosclerosis	0.000352	0.00118	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00035	0.00117	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000348	0.00116	CbGpPWpGaD
Ketamine—DRD2—G alpha (i) signalling events—AGT—focal segmental glomerulosclerosis	0.00034	0.00114	CbGpPWpGaD
Ketamine—SLC6A2—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	0.00034	0.00114	CbGpPWpGaD
Ketamine—SLC6A2—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	0.000339	0.00113	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.000338	0.00113	CbGpPWpGaD
Ketamine—GRIN1—Axon guidance—MMP9—focal segmental glomerulosclerosis	0.000338	0.00113	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.000336	0.00112	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000334	0.00112	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000333	0.00111	CbGpPWpGaD
Ketamine—GRIN2B—Axon guidance—MMP9—focal segmental glomerulosclerosis	0.000329	0.0011	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.000328	0.0011	CbGpPWpGaD
Ketamine—DRD2—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.000326	0.00109	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.000322	0.00108	CbGpPWpGaD
Ketamine—OPRK1—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.000322	0.00108	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—MMP2—focal segmental glomerulosclerosis	0.000321	0.00107	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000318	0.00106	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—MMP2—focal segmental glomerulosclerosis	0.000313	0.00105	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000311	0.00104	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000307	0.00103	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000307	0.00103	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000305	0.00102	CbGpPWpGaD
Ketamine—DRD2—Circadian rythm related genes—SERPINE1—focal segmental glomerulosclerosis	0.000297	0.000992	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000295	0.000986	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.000293	0.00098	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000293	0.000979	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000292	0.000976	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.000286	0.000956	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.000284	0.00095	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.000283	0.000945	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000281	0.000941	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000281	0.000939	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.000272	0.00091	CbGpPWpGaD
Ketamine—DRD2—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.000271	0.000906	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	0.00027	0.000904	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000268	0.000898	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000268	0.000895	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000259	0.000868	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000258	0.000865	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000258	0.000863	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000257	0.000858	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00025	0.000836	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.000248	0.000831	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000247	0.000825	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000247	0.000825	CbGpPWpGaD
Ketamine—ABCB1—Allograft Rejection—TGFB1—focal segmental glomerulosclerosis	0.000245	0.000819	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—MMP9—focal segmental glomerulosclerosis	0.000241	0.000807	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.000239	0.000799	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000238	0.000796	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—MMP9—focal segmental glomerulosclerosis	0.000235	0.000787	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000235	0.000785	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000231	0.000772	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000228	0.000764	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000227	0.000759	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000219	0.000733	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000219	0.000732	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000218	0.000731	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000217	0.000726	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.000217	0.000724	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000216	0.000722	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.000215	0.00072	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000208	0.000697	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000207	0.000694	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000207	0.000692	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.000206	0.00069	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000206	0.000688	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000203	0.000681	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000201	0.000673	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000199	0.000666	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	0.000199	0.000665	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000198	0.000664	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000198	0.000661	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000197	0.000658	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000195	0.000654	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	0.000194	0.000648	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000188	0.00063	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000187	0.000625	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000186	0.000622	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000185	0.00062	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000185	0.000618	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.000184	0.000614	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000183	0.000611	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000182	0.000608	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000181	0.000607	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.000181	0.000606	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00018	0.000603	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000173	0.000578	CbGpPWpGaD
Ketamine—SLC6A2—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	0.000172	0.000576	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000168	0.000563	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000166	0.000554	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000165	0.000553	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000164	0.00055	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000164	0.000547	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000158	0.000529	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000158	0.000528	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000157	0.000527	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000154	0.000514	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000153	0.000513	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000152	0.00051	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000152	0.000508	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000152	0.000507	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00015	0.000503	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.000142	0.000474	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00014	0.000469	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00014	0.000467	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000139	0.000466	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000139	0.000464	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000139	0.000464	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000134	0.000448	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.00013	0.000435	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000128	0.000429	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000128	0.000427	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000127	0.000426	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000123	0.000412	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	0.000121	0.000404	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—LIPC—focal segmental glomerulosclerosis	0.00012	0.000402	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000119	0.000399	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000118	0.000393	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000117	0.000392	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000116	0.00039	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000116	0.000389	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000116	0.000389	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000115	0.000386	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000114	0.000382	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000113	0.000379	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000111	0.000372	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000108	0.000361	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000106	0.000354	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000106	0.000354	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000103	0.000344	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000102	0.00034	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	9.93e-05	0.000332	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	9.76e-05	0.000326	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—GNAQ—focal segmental glomerulosclerosis	9.75e-05	0.000326	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	9.71e-05	0.000325	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	9.7e-05	0.000325	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	9.64e-05	0.000322	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—LPL—focal segmental glomerulosclerosis	9.61e-05	0.000321	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	9.59e-05	0.000321	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	9.15e-05	0.000306	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	9.13e-05	0.000305	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	9.01e-05	0.000302	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—CTGF—focal segmental glomerulosclerosis	8.95e-05	0.0003	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	8.88e-05	0.000297	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	8.86e-05	0.000296	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	8.55e-05	0.000286	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—LIPC—focal segmental glomerulosclerosis	8.28e-05	0.000277	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—GNAQ—focal segmental glomerulosclerosis	8.25e-05	0.000276	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	8.25e-05	0.000276	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—AGT—focal segmental glomerulosclerosis	8.22e-05	0.000275	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	7.8e-05	0.000261	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	7.62e-05	0.000255	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	7.58e-05	0.000254	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	7.53e-05	0.000252	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	7.5e-05	0.000251	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	7.45e-05	0.000249	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—LPL—focal segmental glomerulosclerosis	7.33e-05	0.000245	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	7.3e-05	0.000244	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CTGF—focal segmental glomerulosclerosis	7.29e-05	0.000244	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	7.19e-05	0.00024	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	6.92e-05	0.000231	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GNAQ—focal segmental glomerulosclerosis	6.71e-05	0.000225	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	6.55e-05	0.000219	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	6.34e-05	0.000212	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—ALB—focal segmental glomerulosclerosis	6.31e-05	0.000211	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—AGT—focal segmental glomerulosclerosis	6.27e-05	0.00021	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	6.25e-05	0.000209	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—LPL—focal segmental glomerulosclerosis	6.21e-05	0.000208	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	5.77e-05	0.000193	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	5.75e-05	0.000192	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	5.46e-05	0.000183	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	5.41e-05	0.000181	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	5.4e-05	0.000181	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—AGT—focal segmental glomerulosclerosis	5.31e-05	0.000178	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—LPL—focal segmental glomerulosclerosis	5.05e-05	0.000169	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	4.86e-05	0.000162	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—ALB—focal segmental glomerulosclerosis	4.81e-05	0.000161	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	4.81e-05	0.000161	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	4.8e-05	0.000161	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	4.74e-05	0.000158	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	4.63e-05	0.000155	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.43e-05	0.000148	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—AGT—focal segmental glomerulosclerosis	4.32e-05	0.000145	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—ALB—focal segmental glomerulosclerosis	4.07e-05	0.000136	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	4e-05	0.000134	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.68e-05	0.000123	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	3.55e-05	0.000119	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	3.33e-05	0.000111	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ALB—focal segmental glomerulosclerosis	3.32e-05	0.000111	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.03e-05	0.000101	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	2.85e-05	9.53e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	2.19e-05	7.32e-05	CbGpPWpGaD
